MYC dysregulation in the progression of multiple myeloma.
Leukemia
Misund, Kristine K; Keane, Niamh N; Stein, Caleb K CK; Asmann, Yan W YW; Day, Grady G; Welsh, Seth S; Van Wier, Scott A SA; Riggs, Daniel L DL; Ahmann, Greg G; Chesi, Marta M; Viswanatha, David S DS; Kumar, Shaji K SK; Dispenzieri, Angela A; Gonzalez-Calle, Veronica V; Kyle, Robert A RA; O'Dwyer, Michael M; Rajkumar, S Vincent SV; Kortüm, K Martin KM; Keats, J Jonathan JJ; , ; Fonseca, Rafael R; Stewart, A Keith AK; Kuehl, W Michael WM; Braggio, Esteban E; Bergsagel, P Leif PL
Publication Date: 2020-01
Variant appearance in text: EGFR: 1033T>C; Phe345Leu
Wu, Lucia R LR; Wang, Juexiao Sherry JS; Fang, John Z JZ; Evans, Emily R ER; Pinto, Alessandro A; Pekker, Irena I; Boykin, Richard R; Ngouenet, Celine C; Webster, Philippa J PJ; Beechem, Joseph J; Zhang, David Yu DY
Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.
Cell
Creixell, Pau P; Schoof, Erwin M EM; Simpson, Craig D CD; Longden, James J; Miller, Chad J CJ; Lou, Hua Jane HJ; Perryman, Lara L; Cox, Thomas R TR; Zivanovic, Nevena N; Palmeri, Antonio A; Wesolowska-Andersen, Agata A; Helmer-Citterich, Manuela M; Ferkinghoff-Borg, Jesper J; Itamochi, Hiroaki H; Bodenmiller, Bernd B; Erler, Janine T JT; Turk, Benjamin E BE; Linding, Rune R
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial.
British Journal Of Cancer
Le Tourneau, C C; Paoletti, X X; Servant, N N; Bièche, I I; Gentien, D D; Rio Frio, T T; Vincent-Salomon, A A; Servois, V V; Romejon, J J; Mariani, O O; Bernard, V V; Huppe, P P; Pierron, G G; Mulot, F F; Callens, C C; Wong, J J; Mauborgne, C C; Rouleau, E E; Reyes, C C; Henry, E E; Leroy, Q Q; Gestraud, P P; La Rosa, P P; Escalup, L L; Mitry, E E; Trédan, O O; Delord, J-P JP; Campone, M M; Goncalves, A A; Isambert, N N; Gavoille, C C; Kamal, M M